Papers
5
Total Citations
53
H-Index
3
About
Dr. Yunxiao Liu is a pioneering surgeon-researcher at the forefront of robotic-assisted colorectal cancer surgery and precision oncology. His primary research focuses on evaluating emerging surgical robotic systems—particularly the Chinese-developed KangDuo Surgical Robot—against established platforms like the da Vinci system, with an emphasis on oncologic outcomes and surgical stress responses. Dr. Liu’s landmark prospective cohort study comparing KangDuo and da Vinci Si systems in colon cancer surgery (26 citations) demonstrated non-inferior short-term outcomes, establishing a critical evidence base for expanding access to robotic surgery. His work extends into cancer nanomedicine, where his 2025 review (15 citations) charts the evolution from passive EPR-mediated drug delivery to programmable precision platforms. Notably, Dr. Liu has led multicenter randomized controlled trials examining robotic surgery in elderly colorectal cancer patients, addressing an underserved population. With cumulative citations approaching 60 across his most influential works, Dr. Liu’s contributions are shaping the next generation of surgical robotics and personalized cancer care, bridging technological innovation with rigorous clinical validation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5